158 related articles for article (PubMed ID: 31278380)
1. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning.
Lu JE; Welch RJ; Mishra KK; Daftari IK; Park SS
Eye (Lond); 2019 Dec; 33(12):1904-1910. PubMed ID: 31278380
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
3. Use of high-frequency ultrasound imaging to improve delineation of anterior uveal melanoma for proton irradiation.
Daftari I; Barash D; Lin S; O'Brien J
Phys Med Biol; 2001 Feb; 46(2):579-90. PubMed ID: 11229735
[TBL] [Abstract][Full Text] [Related]
4. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
Verma V; Mehta MP
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
[TBL] [Abstract][Full Text] [Related]
7. Proton beam therapy for the treatment of uveal melanoma in Scotland.
Macdonald EC; Cauchi P; Kemp EG
Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
[TBL] [Abstract][Full Text] [Related]
8. Local recurrence of uveal melanoma after proton beam therapy.
Silva-Rodríguez P; Bande Rodríguez MF; Santiago Varela M; Ruiz-Oliva F; Pardo Perez M; Blanco-Teijeiro MJ; de Trocóniz LLF; Piñeiro Ces A
Clin Exp Optom; 2020 Jul; 103(4):548-549. PubMed ID: 31711260
[No Abstract] [Full Text] [Related]
9. Quantitative echography in primary uveal melanoma treated by proton beam therapy.
Mosci C; Lanza FB; Mosci S; Barla A
Can J Ophthalmol; 2014 Feb; 49(1):60-5. PubMed ID: 24513359
[TBL] [Abstract][Full Text] [Related]
10. Uveal tumour resection.
Char DH; Miller T; Crawford JB
Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
[TBL] [Abstract][Full Text] [Related]
11. Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
[TBL] [Abstract][Full Text] [Related]
12. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
[TBL] [Abstract][Full Text] [Related]
13. Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.
Seibel I; Riechardt AI; Erb-Eigner K; Böker A; Cordini D; Heufelder J; Joussen AM
Am J Ophthalmol; 2018 Jul; 191():49-53. PubMed ID: 29655645
[TBL] [Abstract][Full Text] [Related]
14. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
15. Trabeculectomy in patients with uveal melanoma after proton beam therapy.
Riechardt AI; Cordini D; Rehak M; Hager A; Seibel I; Böker A; Gundlach E; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1379-85. PubMed ID: 26960442
[TBL] [Abstract][Full Text] [Related]
16. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome.
Seibel I; Cordini D; Rehak M; Hager A; Riechardt AI; Böker A; Heufelder J; Weber A; Gollrad J; Besserer A; Joussen AM
Am J Ophthalmol; 2015 Oct; 160(4):628-36. PubMed ID: 26133249
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
[TBL] [Abstract][Full Text] [Related]
18. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
19. Cataract development in patients treated with proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Riechardt AI; Rehak M; Böker A; Böhmer D; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal dexamethasone implant (Ozurdex®) for exudative retinal detachment after proton beam therapy for choroidal melanoma.
Malclès A; Nguyen AM; Mathis T; Grange JD; Kodjikian L
Eur J Ophthalmol; 2017 Aug; 27(5):596-600. PubMed ID: 28218368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
